The primary objective of this pilot study is to develop a CGM-based model to predict the progression from prediabetes to diabetes in individuals with cystic fibrosis.
Study Type
INTERVENTIONAL
Allocation
NON_RANDOMIZED
Purpose
OTHER
Masking
NONE
Enrollment
70
Participants will undergo one-time oral glucose tolerance test (OGTT) and a one-time use of a CGM device, which will be worn for up to 10 days.
Indiana University Health, University Hospital
Indianapolis, Indiana, United States
RECRUITINGCGM Dynamic Index (CDI) for predicting prediabetes in people with cystic fibrosis
Estimating the "optimal" cut-offs of the CDI marker, to distinguish between CF groups
Time frame: 10 days
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.